KNSA logo

Kiniksa Pharmaceuticals International, plc (KNSA)

Profile

Full Name

Kiniksa Pharmaceuticals International, plc

Ticker

NASDAQ: KNSA

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United Kingdom

IPO

May 25, 2018

Indexes

Not included

Website

http://www.kiniksa.com

Employees

315

Key Details

Price

$30.06(-1.02%)

Market cap

$2.19B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$423.24M(+56.60% YoY)

Annual EPS

-$0.60(-400.00% YoY)

PE ratio

-

Next earnings date

Oct 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $30.06
    KNSA price is $30.06

    30-Day Relative Volume

    1.31
    KNSA 30-day relative volume is 1.31

    Price Performance

    Price Today change

    -1.02%
    KNSA price is down -1.02% today

    Price YTD change

    +51.97%
    KNSA price is up +51.97% since January 1st

    Price 1-year change

    +13.52%
    KNSA price is up +13.52% year-on-year

    Price 3-year change

    +203.33%
    KNSA price is up +203.33% over the past 3 years

    Price Range

    Price All-time high

    $32.88
    KNSA price is currently -8.58% below its historical high of $32.88

    Price 3-year low

    $9.63
    KNSA price is currently +212.15% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.19B
    KNSA market capitalization is $2.19 billion

    Market cap 3-year change

    +218.81%
    KNSA market capitalization is up +218.81% over the past 3 years

    Market cap All-time high

    $2.22B
    KNSA market capitalization is currently -1.02% below its historical high of $2.22 billion

    Market cap sector rank

    83.35%
    KNSA market capitalization is higher than 83.35% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.42%
    KNSA shares outstanding is up +2.42% year-on-year

    Shares Outstanding 3-Year Change

    +5.1%
    KNSA shares outstanding is up +5.1% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.67
    KNSA beta is 0.67

    200-day SMA

    $23.46
    KNSA price is currently +28.12% above its 200-day simple moving average

    50-day SMA

    $28.13
    KNSA price is currently +6.87% above its 50-day simple moving average

    RSI

    60.51
    KNSA 14-day relative strength index is 60.51

    Volume

    1.31
    KNSA 30-day relative volume is 1.31

    ATR

    $1.22
    KNSA average true range is $1.22

    10-day Historical Volatility

    70.79%
    KNSA 10-day historical volatility is 70.79%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $423.24M
    KNSA annual revenue is $423.24 million

    Revenue Analysts estimate

    $604.04M
    KNSA annual revenue is currently -29.93% lower than the consensus analysts' forecast

    Revenue 1-year change

    +56.6%
    KNSA annual revenue is up +56.6% year-on-year

    Revenue Sector rank

    72.15%
    KNSA annual revenue is higher than 72.15% of companies in Healthcare sector

    EPS

    EPS

    -$0.60
    KNSA annual earnings per share is -$0.60

    EPS Analysts estimate

    $0.94
    KNSA annual earnings per share is currently -163.84% lower than the consensus analysts' forecast

    EPS 1-year change

    -400%
    KNSA annual earnings per share is down -400% year-on-year

    EPS Sector rank

    64.81%
    KNSA annual earnings per share is higher than 64.81% of companies in Healthcare sector

    Profit

    Gross profit

    $362.33M
    KNSA annual gross profit is $362.33 million

    Gross margin

    85.61%
    KNSA annual gross profit margin is 85.61%

    Operating profit

    -$45.62M
    KNSA annual operating income is -$45.62 million

    Operating margin

    -10.78%
    KNSA annual operating profit margin is -10.78%

    Net income

    -$43.19M
    KNSA annual net profit is -$43.19 million

    Net margin

    -10.21%
    KNSA annual net profit margin is -10.21%

    Expenses

    Total expenses

    $468.86M
    KNSA annual total expenses is $468.86 million

    Operating expenses

    $407.94M
    KNSA annual total operating expenses is $407.94 million

    Cost of goods sold

    $60.91M
    KNSA annual cost of goods sold is $60.91 million

    Selling, general & administrative expenses

    $168.01M
    KNSA annual SGA is $168.01 million

    Depreciation and amortization

    $1.70M
    KNSA annual depreciation & amortization is $1.70 million

    Interest expense

    -
    KNSA annual interest expense value is unknown

    Income tax

    $7.04M
    KNSA annual income tax is $7.04 million

    EBIT & EBITDA

    EBIT

    -$45.62M
    KNSA annual earnings before interest & taxes is -$45.62 million

    EBITDA

    -$43.92M
    KNSA annual EBITDA is -$43.92 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $580.55M
    KNSA annual total assets is $580.55 million

    Non current assets

    $248.75M
    KNSA annual long term assets is $248.75 million

    Current assets

    $331.80M
    KNSA annual total current assets is $331.80 million

    Cash and cash equivalents

    $183.58M
    KNSA annual cash & cash equivalents is $183.58 million

    Accounts receivable

    $41.72M
    KNSA annual accounts receivable is $41.72 million

    Inventory

    $26.36M
    KNSA annual inventory is $26.36 million

    Liabilities

    Total liabilities

    $142.12M
    KNSA annual total liabilities is $142.12 million

    Long term liabilities

    $41.50M
    KNSA annual total long term liabilities is $41.50 million

    Current liabilities

    $100.62M
    KNSA annual total current liabilities is $100.62 million

    Accounts payable

    $2.04M
    KNSA annual accounts payable is $2.04 million

    Debt

    Total debt

    $9.86M
    KNSA annual total debt is $9.86 million

    Total debt 1-year change

    -19.6%
    KNSA annual total debt is down -19.6% year-on-year

    Long term debt

    $7.86M
    KNSA annual long term debt is $7.86 million

    Short term debt

    $1.99M
    KNSA annual short term debt is $1.99 million

    Equity & Capital

    Shareholders equity

    $438.44M
    KNSA annual stockholders equity is $438.44 million

    Book value

    $438.44M
    KNSA annual book value is $438.44 million

    Retained earnings

    -$521.14M
    KNSA annual retained earnings is -$521.14 million

    Working capital

    $231.18M
    KNSA annual working capital is $231.18 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $25.69M
    KNSA annual cash flow from operations is $25.69 million

    Cash from operations 1-year change

    +93.14%
    KNSA annual cash flow from operations is up +93.14% year-on-year

    Cash from investing

    $37.67M
    KNSA annual cash flow from investing activities is $37.67 million

    Cash from investing 1-year change

    +227.46%
    KNSA annual cash flow from investing activities is up +227.46% year-on-year

    Cash from financing

    $12.27M
    KNSA annual cash flow from financing activities is $12.27 million

    Cash from financing 1-year change

    +720.47%
    KNSA annual cash flow from financing activities is up +720.47% year-on-year

    CAPEX

    CAPEX

    $277.00K
    KNSA annual capital expenditures is $277.00 thousand

    CAPEX 1-year change

    +113.08%
    KNSA annual capital expenditures is up +113.08% year-on-year

    Free Cash Flow

    Free cash flow

    $25.41M
    KNSA annual free cash flow is $25.41 million

    Free cash flow 1-year change

    +92.94%
    KNSA annual free cash flow is up +92.94% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    85.61%
    KNSA annual gross profit margin is 85.61%

    Operating margin

    -10.78%
    KNSA annual operating profit margin is -10.78%

    Net margin

    -10.21%
    KNSA annual net profit margin is -10.21%

    ROA & ROE

    ROA

    -7.80%
    KNSA annual return on assets is -7.80%

    ROE

    -9.85%
    KNSA annual return on equity is -9.85%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    KNSA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    KNSA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    4.79
    KNSA price to book ratio is 4.79

    PB ratio Sector rank

    78.99%
    KNSA price to book ratio is higher than 78.99% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.56
    KNSA price to sales ratio is 4.56

    PS ratio Sector rank

    60.45%
    KNSA price to sales ratio is higher than 60.45% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.05B
    KNSA enterprise value is $2.05 billion

    Enterprise value Sector rank

    81.97%
    KNSA enterprise value is higher than 81.97% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -143.82
    KNSA EV/EBITDA is -143.82

    EV/EBITDA Sector rank

    1.23%
    KNSA EV/EBITDA is higher than 1.23% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.30
    KNSA annual current ratio is 3.30

    Quick ratio

    3.04
    KNSA annual quick ratio is 3.04

    Leverage

    Debt to equity

    0.00
    KNSA annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    KNSA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    KNSA piotroski f-score is 4

    Altman Z-Score

    8.95
    KNSA altman z-score is 8.95

    Analyst ratings

    Recent major analysts updates

    Jul 9, 25 Wells Fargo
    Overweight
    Apr 29, 25 Jefferies
    Buy
    Apr 16, 25 Wedbush
    Outperform
    Mar 13, 25 Citigroup
    Buy
    Nov 5, 24 JP Morgan
    Overweight
    Oct 30, 24 Evercore ISI Group
    Outperform
    Jul 23, 24 Wedbush
    Outperform
    May 3, 24 Wells Fargo
    Overweight
    May 1, 24 JP Morgan
    Overweight
    Apr 24, 24 Evercore ISI Group
    Outperform

    Institutional Ownership

    Screeners with KNSA included

    Growing Shares Outstanding
    Mid cap stocks
    UK stocks
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Kiniksa Pharmaceuticals International, plc?
    • Does Kiniksa Pharmaceuticals International, plc pay dividends?
    • What sector is Kiniksa Pharmaceuticals International, plc in?
    • What industry is Kiniksa Pharmaceuticals International, plc in?
    • What country is Kiniksa Pharmaceuticals International, plc based in?
    • When did Kiniksa Pharmaceuticals International, plc go public?
    • Is Kiniksa Pharmaceuticals International, plc in the S&P 500?
    • Is Kiniksa Pharmaceuticals International, plc in the NASDAQ 100?
    • Is Kiniksa Pharmaceuticals International, plc in the Dow Jones?
    • When was Kiniksa Pharmaceuticals International, plc's last earnings report?
    • When does Kiniksa Pharmaceuticals International, plc report earnings?

    What is the ticker symbol for Kiniksa Pharmaceuticals International, plc?

    The ticker symbol for Kiniksa Pharmaceuticals International, plc is NASDAQ:KNSA

    Does Kiniksa Pharmaceuticals International, plc pay dividends?

    No, Kiniksa Pharmaceuticals International, plc does not pay dividends

    What sector is Kiniksa Pharmaceuticals International, plc in?

    Kiniksa Pharmaceuticals International, plc is in the Healthcare sector

    What industry is Kiniksa Pharmaceuticals International, plc in?

    Kiniksa Pharmaceuticals International, plc is in the Specialty & Generic Drug Manufacturers industry

    What country is Kiniksa Pharmaceuticals International, plc based in?

    Kiniksa Pharmaceuticals International, plc is headquartered in United Kingdom

    When did Kiniksa Pharmaceuticals International, plc go public?

    Kiniksa Pharmaceuticals International, plc's initial public offering (IPO) was on May 25, 2018

    Is Kiniksa Pharmaceuticals International, plc in the S&P 500?

    No, Kiniksa Pharmaceuticals International, plc is not included in the S&P 500 index

    Is Kiniksa Pharmaceuticals International, plc in the NASDAQ 100?

    No, Kiniksa Pharmaceuticals International, plc is not included in the NASDAQ 100 index

    Is Kiniksa Pharmaceuticals International, plc in the Dow Jones?

    No, Kiniksa Pharmaceuticals International, plc is not included in the Dow Jones index

    When was Kiniksa Pharmaceuticals International, plc's last earnings report?

    Kiniksa Pharmaceuticals International, plc's most recent earnings report was on July 29, 2025

    When does Kiniksa Pharmaceuticals International, plc report earnings?

    The next expected earnings date for Kiniksa Pharmaceuticals International, plc is October 29, 2025
    On this page